Rabbit Anti-Guinea pig IgG H&L (HRP) (ab6771)
Key features and details
- Rabbit Anti-Guinea pig IgG H&L (HRP)
- Conjugation: HRP
- Host species: Rabbit
- Isotype: IgG
- Suitable for: IHC-Fr, Immunomicroscopy, WB, ICC/IF, Dot blot, ELISA, IHC-P
Related conjugates and formulations
Overview
-
Product name
Rabbit Anti-Guinea pig IgG H&L (HRP)
See all IgG secondary antibodies -
Host species
Rabbit -
Target species
Guinea pig -
Tested applications
Suitable for: IHC-Fr, Immunomicroscopy, WB, ICC/IF, Dot blot, ELISA, IHC-Pmore details -
Immunogen
guinea pig IgG whole molecule
-
Conjugation
HRP
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
Preservative: 0.01% Gentamicin sulphate
Constituents: 0.878% Sodium chloride, 1% BSA, 0.424% Potassium phosphate -
Concentration information loading...
-
Purity
Affinity purified -
Purification notes
This product was prepared from monospecific antiserum by immunoaffinity chromatography using guinea pig IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab6771 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
IHC-Fr |
Use at an assay dependent concentration.
|
|
Immunomicroscopy |
Use at an assay dependent concentration.
|
|
WB |
Use at an assay dependent dilution.
|
|
ICC/IF |
1/500 - 1/2500.
|
|
Dot blot |
Use at an assay dependent concentration.
|
|
ELISA |
Use at an assay dependent dilution.
|
|
IHC-P |
Use at an assay dependent concentration.
|
Notes |
---|
IHC-Fr
Use at an assay dependent concentration. |
Immunomicroscopy
Use at an assay dependent concentration. |
WB
Use at an assay dependent dilution. |
ICC/IF
1/500 - 1/2500. |
Dot blot
Use at an assay dependent concentration. |
ELISA
Use at an assay dependent dilution. |
IHC-P
Use at an assay dependent concentration. |
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
Datasheet download
References (19)
ab6771 has been referenced in 19 publications.
- Farooqui N et al. Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors. Kidney Int Rep 8:628-641 (2023). PubMed: 36938084
- Root-Bernstein R et al. Clostridia and Enteroviruses as Synergistic Triggers of Type 1 Diabetes Mellitus. Int J Mol Sci 24:N/A (2023). PubMed: 37176044
- Root-Bernstein R et al. SARS-CoV-2 and Its Bacterial Co- or Super-Infections Synergize to Trigger COVID-19 Autoimmune Cardiopathies. Int J Mol Sci 24:N/A (2023). PubMed: 37569555
- Külshammer E et al. The mechanosensor Filamin A/Cheerio promotes tumourigenesis via specific interactions with components of the cell cortex. FEBS J 289:4497-4517 (2022). PubMed: 35191183
- Root-Bernstein R et al. Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies. Int J Mol Sci 23:N/A (2022). PubMed: 36232795